About Kevin Lynch
Form D filings for S1P Therapeutics in 2023 list Kevin Lynch as executive officer and director.
Kevin Lynch first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Kevin Lynch in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Kevin Lynch works with at each company, as listed on that company's latest Form D.
S1P Therapeutics Inc. · Form D, Jun 9, 2023
WS
Webster Santos
Executive officer and director
RS
Ronald Sayco
Chief Executive Officer and director